Brandywine Realty Trust is a REIT focused on owning, managing, and developing office, life science, and mixed-use properties primarily in Philadelphia (CBD and suburbs) and Austin, Texas. Brandywine operates as a fully integrated real estate company, handling property management, leasing, development, and construction in-house. The company leases space to corporate tenants across financial services, technology, healthcare, and professional services, targeting what it calls "flight to quality" tenants seeking premium, amenity-rich buildings in central business districts and transit-oriented locations. Revenue is driven by occupancy rates and rental mark-to-markets as leases expire and re-price to market. Brandywine's Philadelphia CBD portfolio is its strongest, running near full occupancy, while its Austin portfolio remains a drag at around 74% occupied. The company is in the final stages of two major mixed-use development campuses — Schuylkill Yards in Philadelphia and Uptown ATX in Austin — with key assets including the 3151 Market life science building and One Uptown office tower still in lease-up. These developments were partially funded through institutional preferred equity joint ventures, which create a significant non-cash earnings drag until recapitalized. Brandywine's near-term priorities are deleveraging through roughly $280-$300M of asset sales, stabilizing its development pipeline, and converting preferred equity JV structures into lower-cost debt to improve earnings. Brandywine also earns management and development fees from third-party owners and JV partners, though this revenue stream is expected to shrink as joint ventures stabilize.